Borderline ovarian epithelial cancer
Tresukosol, D.; Triratanachat, S.
Journal of the Medical Association of Thailand 87(Suppl 3): S120-S123
2004
ISSN/ISBN: 0125-2208 PMID: 21213507 Document Number: 11216
Document emailed within 1 workday
Related Documents
Wertheim, I.; Tangir, J.; Muto, M.G.; Welch, W.R.; Berkowitz, R.S.; Chen, W.Y.; Mok, S.C. 1996: Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors Oncogene 12(10): 2147-2153Studziński, Z.; Filipczak, A.; Branicka, D. 1999: Coexistence of ovarian epithelial tumor of borderline malignancy with pregnancy: a case report Ginekologia Polska 70(2): 101-104
Rodabaugh, K.J.; Biggs, R.B.; Qureshi, J.A.; Barrett, A.J.; Welch, W.R.; Bell, D.A.; Berkowitz, R.S.; Mok, S.C. 1995: Detailed deletion mapping of chromosome 9p and p16 gene alterations in human borderline and invasive epithelial ovarian tumors Oncogene 11(7): 1249-1254
Kumle, M.; Weiderpass, E.; Braaten, T.; Adami, H.O.; Lund, E. 2004: Risk for invasive and borderline epithelial ovarian neoplasias following use of hormonal contraceptives: the Norwegian Swedish Women's Lifestyle and Health Cohort Study British Journal of Cancer 90(7): 1386-1391
Kumle, M.; Weiderpass, E.; Braaten, T.; Adami, H.O.; Lund, E. 2004: Risk for invasive and borderline epithelial ovarian neoplasias following use of hormonal contraceptives: the Norwegian Swedish Women's Lifestyle and Health Cohort Study British Journal of Cancer 90(7): 1386-1391
Jin, Z.; Gu, J.; Xin, X.; Li, Y.; Wang, H. 2014: Expression of hexokinase 2 in epithelial ovarian tumors and its clinical significance in serous ovarian cancer European Journal of Gynaecological Oncology 35(5): 519-524
Jacobs, I.J.; Smith, S.A.; Wiseman, R.W.; Futreal, P.A.; Harrington, T.; Osborne, R.J.; Leech, V.; Molyneux, A.; Berchuck, A.; Ponder, B.A. 1993: A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus Cancer Research 53(6): 1218-1221
Feng, Z.; Wen, H.; Liao, Q. 2014: Expression of Notch1, Jagged1 and NICD in epithelial ovarian carcinomas and a preliminary study on the activity of gamma-secretase in epithelial ovarian carcinoma cell lines Zhonghua Fu Chan Ke Za Zhi 49(10): 780-786
Gojnic, M.; Dugalic, V.; Vidaković, S.; Papic, M.; Jeremic, K.; Pervulov, M.; Milicevic, S. 2005: Breast cancer and borderline ovarian carcinoma in young patients--case report European Journal of Gynaecological Oncology 26(5): 579-580
Schmuck, R.B.; Pietzner, K.; Buckendahl, A.; Schönlebe, J.; Sehouli, J. 2010: Cervical manifestation of a borderline type ovarian cancer with pseudomyxoma peritonei - a case report Anticancer Research 30(7): 2991-2994
Djordjevic, B.; Stojanovic, S.; Conic, I.; Jankovic-Velickovic, L.; Vukomanovic, P.; Zivadinovic, R.; Vukadinovic, M. 2012: Current approach to epithelial ovarian cancer based on the concept of cancer stem cells Journal of BUON: Official Journal of the Balkan Union of Oncology 17(4): 627-636
Wang, J.; Li, A.J.; Karlan, B.Y. 2002: Chemotherapy in epithelial ovarian cancer Current Women's Health Reports 2(1): 20-26
Ding, X.; Lang, J.; Shen, K. 1999: Recurrent epithelial ovarian cancer Zhonghua Fu Chan Ke Za Zhi 34(1): 30-32
Memarzadeh, S.; Berek, J.S. 2001: Advances in the management of epithelial ovarian cancer Journal of Reproductive Medicine 46(7): 621-9; Discussion 629-30
Soonthornthum, T.; Suraseraneewong, V.; Kengsakol, K.; Wijaithum, K.; Kasemsan, P.; Prommatt, S. 2007: Thrombocytosis in advanced epithelial ovarian cancer Journal of the Medical Association of Thailand 90(8): 1495-1500
Sparholt, M.H.; Høgdall, E.; Høgdall, C.K. 2009: Tumour markers in epithelial ovarian cancer Ugeskrift for Laeger 171(48): 3505-3509
Kavanagh, J.J.; Nicaise, C. 1989: Carboplatin in refractory epithelial ovarian cancer Seminars in Oncology 16(2 Suppl 5: 45-48
Nozawa, S.; Aoki, D.; Yajima, M.; Tsukazaki, K.; Kobayashi, T.; Kimura, E.; Terashima, Y.; Inaba, N.; Takamizawa, H.; Negishi, Y. 1992: CA54/61 as a marker for epithelial ovarian cancer Cancer Research 52(5): 1205-1209
Živný, J.H.; Leahomschi, S.; Klener, P.; Živný, J.; Haluzík, M.; Cibula, D. 2016: Comparison of Plasma Osteopontin Levels between Patients with Borderline Ovarian Tumours and Serous Ovarian Carcinoma Folia Biologica 62(6): 258-262
Katsaros, D.; Yu, H.; Piccinno, R.; Puopolo, M.; Rigault De La Longrais, I.A.; Fracchioli, S.; Massobrio, M. 2002: Expression and prognostic significance in epithelial ovarian cancer Minerva Ginecologica 54(1): 15-24